ObsEva appoints David Renas as Chief Financial Officer
04 janv. 2021 01h00 HE
|
ObsEva SA
Geneva, Switzerland and Boston, MA – January 4, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve...